Taken together, we show that overexpression of UCH-L1 contributes to loss or reduction of ERα in breast cancer, and this is mediated by its deubiquitinating and stabilizing effects on EGFR, which transcriptionally represses the expression of ERα. The gene discussed is ESR1; the disease is breast cancer.